<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="medium, provided the original work is properly cited. Abstract Non-alcoholic" exact="fatty liver disease" post="(NAFLD) is the most common chronic liver disease, however"/>
 <result pre="provided the original work is properly cited. Abstract Non-alcoholic fatty" exact="liver disease" post="(NAFLD) is the most common chronic liver disease, however"/>
 <result pre="Non-alcoholic fatty liver disease (NAFLD) is the most common chronic" exact="liver disease," post="however the exact cause of NAFLD remains unknown. Methionine,"/>
 <result pre="the beneficial effects of SPD against CDD-induced liver damage. non-alcoholic" exact="fatty liver disease" post="methionine soy protein prohibitin 1 isoflavone INTRODUCTION Non-alcoholic fatty"/>
 <result pre="beneficial effects of SPD against CDD-induced liver damage. non-alcoholic fatty" exact="liver disease" post="methionine soy protein prohibitin 1 isoflavone INTRODUCTION Non-alcoholic fatty"/>
 <result pre="liver disease methionine soy protein prohibitin 1 isoflavone INTRODUCTION Non-alcoholic" exact="fatty liver disease" post="(NAFLD) is currently the most common chronic liver disease"/>
 <result pre="disease methionine soy protein prohibitin 1 isoflavone INTRODUCTION Non-alcoholic fatty" exact="liver disease" post="(NAFLD) is currently the most common chronic liver disease"/>
 <result pre="fatty liver disease (NAFLD) is currently the most common chronic" exact="liver disease" post="( 1). The estimated prevalence of NAFLD is approximately"/>
 <result pre="as simple hepatic steatosis, nonalcoholic steatohepatitis (NASH), progressive fibrosis, and" exact="cirrhosis" post="( 3). These diseases can develop into liver failure"/>
 <result pre="oxidative stress and liver tumors ( 13). In patients with" exact="liver disease," post="enzymes such as MAT1A, glycine N-methyl-transferase (GNMT), and cystathionine"/>
 <result pre="effects, hypotensive activity, and protection against metabolic diseases such as" exact="obesity" post="or diabetes ( 18– 22). However, little is known"/>
 <result pre="and subcellular location ( 23). The role of PHB1 in" exact="cancer" post="remains controversial, however it has been reported that PHB1"/>
 <result pre="weeks ( 25). Expression of Phb1 is closely related to" exact="liver disease" post="susceptibility, and a number of relevant studies are currently"/>
 <result pre="knockout mice, it is impossible to examine the sensitivity of" exact="liver disease" post="due to severe liver damage from birth. Therefore, it"/>
 <result pre="fed the CDD and SPD are not affected by severe" exact="liver disease." post="Serum ALT and AST levels were additionally assessed ("/>
 <result pre="liver-specific Phb1 +/− mice fed the SPD. In patients with" exact="liver disease," post="hepatic mRNA expression of Mat1a, Gnmt, Bhmt, Cbs, and"/>
 <result pre="genes such as Sahh ( 49, 50), are vulnerable to" exact="liver disease." post="Thus, abnormal methionine metabolism by methionine-deficient soy protein is"/>
 <result pre="interest. References REFERENCES 1 Wieckowska A Feldstein AE 2005 Nonalcoholic" exact="fatty liver disease" post="in the pediatric population: a review Curr Opin Pediatr"/>
 <result pre="References REFERENCES 1 Wieckowska A Feldstein AE 2005 Nonalcoholic fatty" exact="liver disease" post="in the pediatric population: a review Curr Opin Pediatr"/>
 <result pre="16160540 2 Machado M Cortez-Pinto H 2006 Non-alcoholic steatohepatitis and" exact="metabolic syndrome" post="Curr Opin Clin Nutr Metab Care 9 637 642"/>
 <result pre="Larter CZ 2006 Nonalcoholic fatty liver disease: from steatosis to" exact="cirrhosis" post="Hepatology 43 S99 S112 10.1002/hep.20973 16447287 4 Zafrani ES"/>
 <result pre="SS Diehl AM 2008 Mechanisms of disease progression in nonalcoholic" exact="fatty liver disease" post="Semin Liver Dis 28 370 379 10.1055/s-0028-1091981 18956293 7"/>
 <result pre="Diehl AM 2008 Mechanisms of disease progression in nonalcoholic fatty" exact="liver disease" post="Semin Liver Dis 28 370 379 10.1055/s-0028-1091981 18956293 7"/>
 <result pre="Mato JM Martínez-Chantar ML Lu SC 2008 Methionine metabolism and" exact="liver disease" post="Annu Rev Nutr 28 273 293 10.1146/annurev.nutr.28.061807.155438 18331185 15"/>
 <result pre="MT Bhathena SJ 2007 Role of dietary soy protein in" exact="obesity" post="Int J Med Sci 4 72 82 10.7150/ijms.4.72 17396158"/>
 <result pre="of prohibitin 1 results in spontaneous liver injury, fibrosis, and" exact="hepatocellular carcinoma" post="in mice Hepatology 52 2096 2108 10.1002/hep.23919 20890892 25"/>
 <result pre="J 2004 Oxidative stress-related parameters in the liver of non-alcoholic" exact="fatty liver disease" post="patients Clin Sci 106 261 268 10.1042/CS20030285 14556645 33"/>
 <result pre="2004 Oxidative stress-related parameters in the liver of non-alcoholic fatty" exact="liver disease" post="patients Clin Sci 106 261 268 10.1042/CS20030285 14556645 33"/>
 <result pre="10.1097/AIA.0b013e318034194e 17426506 36 Coussens LM Werb Z 2002 Inflammation and" exact="cancer" post="Nature 420 860 867 10.1038/nature01322 12490959 37 Tracey KJ"/>
 <result pre="serum lipids and renal fibrogenic cytokines in rats with chronic" exact="nephrotic syndrome" post="J Nutr 132 2562 2569 10.1093/jn/132.9.2562 12221209 40 Masilamani"/>
 <result pre="the main enzymes involved in methionine metabolism in human liver" exact="cirrhosis" post="and hepatocellular carcinoma J Hepatol 33 907 914 10.1016/S0168-8278(00)80122-1"/>
 <result pre="enzymes involved in methionine metabolism in human liver cirrhosis and" exact="hepatocellular carcinoma" post="J Hepatol 33 907 914 10.1016/S0168-8278(00)80122-1 11131452 42 Horowitz"/>
 <result pre="Daniel R 1981 Evidence for impairment of transsulfuration pathway in" exact="cirrhosis" post="Gastroenterology 81 668 675 7262512 43 Corrales F Alvarez"/>
 <result pre="Ortiz P Mato JM 1992 Impairment of methionine metabolism in" exact="liver disease" post="Drug Invest 4 8 13 10.1007/BF03258359 44 Lu SC"/>
 <result pre="Huang SF Chen YM 2007 Glycine N-methyltransferase−/− mice develop chronic" exact="hepatitis" post="and glycogen storage disease in the liver Hepatology 46"/>
 <result pre="Chen YM 2007 Glycine N-methyltransferase−/− mice develop chronic hepatitis and" exact="glycogen storage disease" post="in the liver Hepatology 46 1413 1425 10.1002/hep.21863 17937387"/>
 <result pre="Loss of the glycine N-methyltransferase gene leads to steatosis and" exact="hepatocellular carcinoma" post="in mice Hepatology 47 1191 1199 10.1002/hep.22159 18318442 47"/>
 <result pre="Xing C Gotway G Cohen JC Hobbs HH 2015 Adult-onset" exact="liver disease" post="and hepatocellular carcinoma in S-adenosylhomocysteine hydrolase deficiency Mol Genet"/>
 <result pre="G Cohen JC Hobbs HH 2015 Adult-onset liver disease and" exact="hepatocellular carcinoma" post="in S-adenosylhomocysteine hydrolase deficiency Mol Genet Metab 116 269"/>
</results>
